Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of varicose veins coupled with rising awareness regarding its treatment
3.2.1.2 Growing preference for minimally invasive procedures
3.2.1.3 Rise in number of orthopedic procedures
3.2.1.4 Technological advancements pertaining to chronic venous insufficiency treatment therapies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and risks associated with different treatment modes
3.2.2.2 Strict regulatory guidelines
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Treatment landscape
3.7 Future market trends
3.8 Technological landscape
3.9 Epidemiology scenario
3.10 Porter's analysis
3.11 PESTEL analysis
3.12 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Devices
5.2.1 Compression devices
5.2.2 Endovenous ablation
5.2.2.1 Laser ablation
5.2.2.2 Radiofrequency ablation
5.2.3 Sclerotherapy
5.2.4 Vein stripper
5.2.5 Other devices
5.3 Drugs
5.3.1 Analgesics
5.3.2 Antibiotics
5.3.3 Anticoagulants
5.3.4 Other drugs
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Varicose veins
6.3 Venous stasis ulcers
6.4 Edema
6.5 Deep vein thrombosis
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 3M Company
9.2 Bayer AG
9.3 Boston Scientific Corporation
9.4 Candela
9.5 ConvaTec Inc.
9.6 Fotona
9.7 Julius Zorn GmbH
9.8 Leucadia Pharmaceuticals (Hikma)
9.9 Medi GmbH & Co. KG
9.10 Medtronic plc
9.11 Merz Pharma
9.12 Pfizer Inc.
9.13 Sanofi
9.14 Sciton, Inc
9.15 Tactile Medical
9.16 Venclose, Inc. (Becton Dickinson and Company)
9.17 Viatris Inc.
